Navigation Links
MRIGlobal Wins 12th Contract for NCI Program
Date:8/3/2012

KANSAS CITY, Mo., Aug. 3, 2012 /PRNewswire-USNewswire/ -- MRIGlobal today announced that it has been awarded a 12th consecutive contract from the National Cancer Institute to operate the Anti-Cancer Chemicals and Pharmaceutical Formulations Analysis Program.

The contract, for a five-year term, is valued at $3.8 million. In this continuing program, MRIGlobal performs analysis of bulk pharmaceutical substances and formulated drug products under strict quality control standards known in the industry as "current Good Manufacturing Practices."

"We're proud to be continuing our robust history of support for the National Cancer Institute," said Michael F. Helmstetter, Ph.D., President and Chief Executive Officer of MRIGlobal. "Our work advances the goal of delivering a world without cancer."

MRIGlobal performs analyses that support the development of anti-cancer chemicals and pharmaceuticals that are typically in pre-approval phases, and MRIGlobal's analyses are performed to meet requirements of the U.S. Food and Drug Administration.

MRIGlobal uses spectroscopy, chromatography, and electrochemical analyses, among other complex technical tests, to investigate these drugs. In the 43 years of operation of the program, MRIGlobal has completed more than 2,000 analytical reports on small organic molecules, complex antibiotics, proteins and other compounds.

This project has been funded in whole or in part with Federal funds from the National Cancer Institute, National Institutes of Health, Department of Health and Human Services, under Contract No. HHSN26201200026C.

For more information, visit www.mriglobal.org.


'/>"/>
SOURCE MRIGlobal
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. QBC Diagnostics Awarded GSA Contract
2. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
3. Biomedical Advanced Research and Development Authority (BARDA) Exercises Option with Pfenex Inc. To Extend Contract for the Development of a Recombinant Protective Antigen (rPA) Based Anthrax Vaccine
4. Novation Inks Supplier Contract Category Agreement for Masimo SET® pulse oximetry and rainbow® SET Pulse CO-Oximetry™
5. Nonin Medical Awarded Novation Contract for Clinically Proven Pulse Oximeters
6. Bacterin International Signs Its Third National GPO Contract with Novation
7. Contract Research Organizations Set to Experience Rapid Growth as Development Costs for New Drugs Continue to Rise
8. SurgiCount Medical Awarded Contract From HealthTrust Purchasing Group for the Safety-Sponge® System
9. Kansas City Region Launches Contract Research Initiative To Speed The Development Of Health Care Innovation Worldwide
10. Centene Corporation Selected for Ohio Medicaid Contract
11. Emerging Trends in Medical Device Outsourcing and Contract Manufacturing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... 2017 Global Prostate Cancer Therapeutics Market: ... prostate cancer therapeutics market analyzes the current and ... of prostate cancer, launch of promising emerging therapies, ... new drugs & therapeutic biological products, and high ... lesser side effects are some of the drivers ...
(Date:4/19/2017)... , April 19, 2017  Sorrento Therapeutics, ... antibody-centric, clinical-stage biopharmaceutical company developing new treatments for ... the closing of its previously announced underwritten public ... at a public offering price of $2.00 per ... estimated offering expenses payable by Sorrento.  The net ...
(Date:4/19/2017)... N.J. , April 19, 2017  Novartis ... by the National Heart, Lung, and Blood Institute ... demonstrating that 58% of patients with treatment-naïve severe ... months when treated with eltrombopag at the initiation ... . The study evaluated three sequential treatment groups, ...
Breaking Medicine Technology:
(Date:4/25/2017)... ... 25, 2017 , ... Patients who would like to straighten ... fraction of the time as traditional braces – Wilckodontics®. Dr. Victoria Chen, an ... this revolutionary treatment with or without a referral. , Wilckodontics is also ...
(Date:4/25/2017)... ... April 25, 2017 , ... Buyers and sellers in the thriving multi-billion ... head shops –can’t help but be heartened by the industry’s current surge. But another ... described as “skunk smell.” At last they can simply, safely and effectively end ...
(Date:4/25/2017)... ... ... There is no better place in South Florida to undergo two common heart ... of Consumer Reports focused on heart health. , The magazine gave Memorial ... bypass and aortic valve replacement procedures. , Consumer Reports rated Memorial’s Cardiac ...
(Date:4/24/2017)... , ... April 24, 2017 , ... ... yesterday, featuring Bring Your Own Device (BYOD) capabilities at Telehealth 2.0, the American ... pre-packaged telehealth bundles, which pairs medical devices with a pre-programmed tablet in a ...
(Date:4/24/2017)... ... 2017 , ... As part of the nationwide Days of Remembrance effort led ... Holocaust and Nazi persecution, Center for Medicine after the Holocaust (CMATH) announced ... trip to Germany and Poland next week. , The Fourth Biennial CMATH Champions Trip ...
Breaking Medicine News(10 mins):